Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bispecific and multispecific T-cell engagers: advancing the future of immunotherapy. | Antib Ther | 2026 | 41561192 | PubTator, text mining | PubMed |
| Primary poorly differentiated enteric-type adenocarcinoma of the thymus with characteristic intracytoplasmic vacuoles on cytology. | Respir Med Case Rep | 2026 | 41552789 | PubTator, text mining | PubMed |
| Biomarkers of activity from a phase I study of cergutuzumab amunaleukin in patients with advanced solid tumors. | J Immunother Cancer | 2026 | 41545306 | PubTator, text mining | PubMed |
| The making of multispecific immunoglobulins - a clinical perspective. | MAbs | 2026 | 41542910 | PubTator, text mining | PubMed |
| Molecular alteration profiles characterize intraductal carcinoma of the prostate. | Cancer | 2026 | 41457395 | PubTator, text mining | PubMed |
| Biomarker analysis from a Phase 1/1b study of tusamitamab ravtansine in patients with advanced non-small cell lung cancer. | Transl Oncol | 2026 | 41337813 | PubTator, text mining | PubMed |
| Antibody-guided AAV vectors for antigen-specific delivery of suicide genes. | Gene Ther | 2026 | 41298904 | PubTator, text mining | PubMed |
| Next-generation proteomics improves lung cancer risk prediction. | Mol Oncol | 2026 | 41264374 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in lung cancer: current landscape and future perspectives. | Curr Opin Oncol | 2026 | 41222552 | PubTator, text mining | PubMed |
| Oral Administration of Trifluoroacetyl Chitosan-Encapsulated Redshifted Immunofluorophore for NIR-II Bioimaging of Colorectal Metastases. | Adv Healthc Mater | 2026 | 41097850 | PubTator, text mining | PubMed |
| Computational theranostics strategy for pancreatic ductal adenocarcinoma. | Mol Divers | 2026 | 40522604 | PubTator, text mining | PubMed |
| Advances in Cervical Cancer Diagnostics Based on Immunosensors: Innovative Approaches and Tumor Biomarkers. | Curr Top Med Chem | 2026 | 40192049 | PubTator, text mining | PubMed |
| Expanding the potential of antibody-drug conjugates in gastrointestinal malignancies: beyond HER2 targets. | ESMO Gastrointest Oncol | 2025 | 41646266 | PubTator, text mining | PubMed |
| Primary Cutaneous Cribriform Apocrine Carcinoma: A Case Report and Narrative Review. | BioMed (Basel) | 2025 | 41551756 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal the interaction between PRRX2-driven epithelial cells and SPP1+ macrophages in mediating gemcitabine resistance in pancreatic ductal adenocarcinoma. | Chin Med J (Engl) | 2025 | 41456929 | PubTator, text mining | PubMed |
| Data-driven identification and semi-automated quantification of molecular targets for tumour-imaging of colorectal liver metastases and primary colorectal tumours. | EJNMMI Res | 2025 | 41444844 | PubTator, text mining | PubMed |
| Integrative analysis reveals prognostic value of cuproptosis and copper hemostasis related genes in immunotherapy for non-small cell lung cancer. | NPJ Precis Oncol | 2025 | 41266534 | PubTator, text mining | PubMed |
| Antibody-drug conjugates as immuno-oncology agents in colorectal cancer: targets, payloads, and therapeutic synergies. | Front Immunol | 2025 | 41256852 | PubTator, text mining | PubMed |
| MiR-5095 inhibits proliferation, migration, and invasion of gastric cancer cells by targeting CEACAM5. | Sci Rep | 2025 | 41238651 | PubTator, text mining | PubMed |
| Production of monoclonal antibodies against carcinoembryonic antigen-related cell adhesion molecule 6 and detection of their binding affinities. | Tzu Chi Med J | 2025 | 41180515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=5